Generic competition in the pharmaceutical industry

被引：1

作者：

Saha, A

Grabowski, H

Birnbaum, HG

Bizan, O

Greenberg, PE

Whitney, S

机构：

[1] Anal Grp Econ, New York, NY USA

[2] Duke Univ, Durham, NC USA

[3] Anal Grp Econ, Boston, MA USA

来源：

VALUE IN HEALTH | 2003年 / 6卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)63871-5

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：207 / 207

页数：1

共 50 条

[21] The pharmaceutical industry of Puerto Rico: Ramifications of global competition
Ramcharran, Harri
JOURNAL OF POLICY MODELING, 2011, 33 (03) : 395 - 406
[22] COMPETITION IN THE PHARMACEUTICAL-INDUSTRY - GERMAN - ROPER,B
OBERENDER, P
JAHRBUCHER FUR NATIONALOKONOMIE UND STATISTIK, 1982, 197 (01): : 88 - 91
[23] DOES PHARMACEUTICAL PRICE REGULATION AFFECT THE ADOPTION OF GENERIC COMPETITION IN THE OECD?
Varol, N.
Costa-i-Font, J.
McGuire, A. J.
VALUE IN HEALTH, 2011, 14 (07) : A336 - A336
[24] Impact of European Pharmaceutical Price Regulation on Generic Price Competition A Review
Puig-Junoy, Jaume
PHARMACOECONOMICS, 2010, 28 (08) : 649 - 663
[25] COMPETITION AND MARKETING STRATEGIES IN PHARMACEUTICAL INDUSTRY - SLATTER,SSP
BARNA, T
ECONOMIC JOURNAL, 1978, 88 (349): : 147 - 148
[26] GENERIC SUBSTITUTION IN THE UK PHARMACEUTICAL-INDUSTRY - A MARKOVIAN ANALYSIS
REEKIE, WD
ALLEN, DE
MANAGERIAL AND DECISION ECONOMICS, 1985, 6 (02) : 93 - 101
[27] The achievements and problems of the production of generic drug substances for pharmaceutical industry
Skornyakov, Yu. V.
Skornyakova, O. V.
RUSSIAN CHEMICAL BULLETIN, 2015, 64 (07) : 1696 - 1699
[28] The achievements and problems of the production of generic drug substances for pharmaceutical industry
Yu. V. Skornyakov
O. V. Skornyakova
Russian Chemical Bulletin, 2015, 64 : 1696 - 1699
[29] Horizontal integration between brand and generic firms in the pharmaceutical industry
Morton, FMS
JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY, 2002, 11 (01) : 135 - 168
[30] Dynamic competition in pharmaceuticalsPatent expiry, generic penetration, and industry structure
Laura Magazzini
Fabio Pammolli
Massimo Riccaboni
The European Journal of Health Economics, formerly: HEPAC , 2004, 5 (2): : 175 - 182

← 1 2 3 4 5 →